LLY Relative Valuation
LLY's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, LLY is overvalued; if below, it's undervalued.
Historical Valuation
Eli Lilly and Co (LLY) is now in the Fair zone, suggesting that its current forward PE ratio of 32.59 is considered Fairly compared with the five-year average of 40.18. The fair price of Eli Lilly and Co (LLY) is between 916.05 to 1503.74 according to relative valuation methord.
Relative Value
Fair Zone
916.05-1503.74
Current Price：1014.49
Fair
32.59
PE
1Y
3Y
5Y
Trailing
Forward
25.41
EV/EBITDA
Eli Lilly and Co. (LLY) has a current EV/EBITDA of 25.41. The 5-year average EV/EBITDA is 30.05. The thresholds are as follows: Strongly Undervalued below 14.66, Undervalued between 14.66 and 22.36, Fairly Valued between 37.74 and 22.36, Overvalued between 37.74 and 45.43, and Strongly Overvalued above 45.43. The current Forward EV/EBITDA of 25.41 falls within the Historic Trend Line -Fairly Valued range.
27.36
EV/EBIT
Eli Lilly and Co. (LLY) has a current EV/EBIT of 27.36. The 5-year average EV/EBIT is 34.96. The thresholds are as follows: Strongly Undervalued below 15.49, Undervalued between 15.49 and 25.23, Fairly Valued between 44.70 and 25.23, Overvalued between 44.70 and 54.43, and Strongly Overvalued above 54.43. The current Forward EV/EBIT of 27.36 falls within the Historic Trend Line -Fairly Valued range.
12.69
PS
Eli Lilly and Co. (LLY) has a current PS of 12.69. The 5-year average PS is 10.99. The thresholds are as follows: Strongly Undervalued below 5.20, Undervalued between 5.20 and 8.10, Fairly Valued between 13.88 and 8.10, Overvalued between 13.88 and 16.77, and Strongly Overvalued above 16.77. The current Forward PS of 12.69 falls within the Historic Trend Line -Fairly Valued range.
38.35
P/OCF
Eli Lilly and Co. (LLY) has a current P/OCF of 38.35. The 5-year average P/OCF is 38.45. The thresholds are as follows: Strongly Undervalued below 15.19, Undervalued between 15.19 and 26.82, Fairly Valued between 50.08 and 26.82, Overvalued between 50.08 and 61.71, and Strongly Overvalued above 61.71. The current Forward P/OCF of 38.35 falls within the Historic Trend Line -Fairly Valued range.
58.16
P/FCF
Eli Lilly and Co. (LLY) has a current P/FCF of 58.16. The 5-year average P/FCF is 50.68. The thresholds are as follows: Strongly Undervalued below 15.60, Undervalued between 15.60 and 33.14, Fairly Valued between 68.22 and 33.14, Overvalued between 68.22 and 85.77, and Strongly Overvalued above 85.77. The current Forward P/FCF of 58.16 falls within the Historic Trend Line -Fairly Valued range.
Eli Lilly and Co (LLY) has a current Price-to-Book (P/B) ratio of 38.20. Compared to its 3-year average P/B ratio of 45.85 , the current P/B ratio is approximately -16.70% higher. Relative to its 5-year average P/B ratio of 39.54, the current P/B ratio is about -3.40% higher. Eli Lilly and Co (LLY) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 0.63%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 1.43% , the current FCF yield is about -100.00% lower.
38.20
P/B
Median3y
45.85
Median5y
39.54
1.00
FCF Yield
Median3y
0.63
Median5y
1.43
Competitors Valuation Multiple
The average P/S ratio for LLY's competitors is 3.66, providing a benchmark for relative valuation. Eli Lilly and Co Corp (LLY) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 53.87%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of LLY increased by 31.41% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 8.48 to 31.72.
The secondary factor is the Revenue Growth, contributed 53.87%to the performance.
Overall, the performance of LLY in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Eli Lilly and Co (LLY) currently overvalued or undervalued?
What is Eli Lilly and Co (LLY) fair value?
How does LLY's valuation metrics compare to the industry average?
What is the current P/B ratio for Eli Lilly and Co (LLY) as of Dec 05 2025?
What is the current FCF Yield for Eli Lilly and Co (LLY) as of Dec 05 2025?
What is the current Forward P/E ratio for Eli Lilly and Co (LLY) as of Dec 05 2025?